| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And President
1 company
Knie Robb serves as a CEO And President at HOTH. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $662K at current prices.
Historically, Knie Robb's trades have earned a below-average insider score of 44/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -27.3%.
The biggest single holding is HOTH (~$662K) as CEO And President. Net of sales, the recent Form 4 record there shows accumulation of 45,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | HOTH Hoth Therapeutics, Inc. | CEO And President | Buy | 25,000 | $0.67 | $16,750.00 | +75.5% | +20.1% | +81.8% | |
| Sep 19, 2022 | HOTH Hoth Therapeutics, Inc. | CEO And President | Buy | 10,000 | $0.39 | $3,900.00 | +1.2% | -69.4% | -82.8% | |
| Sep 16, 2022 | HOTH Hoth Therapeutics, Inc. | CEO And President | Buy | 10,000 | $0.40 | $4,000.00 | +1.2% | -56.7% | -80.9% |